Non-coding RNAs (ncRNAs) and multidrug resistance in glioblastoma: Therapeutic challenges and opportunities

GM Subaiea, RU Syed, S Afsar, TMS Alhaidan… - … -Research and Practice, 2024 - Elsevier
Non-coding RNAs (ncRNAs) have been recognized as pivotal regulators of transcriptional
and post-transcriptional gene modulation, exerting a profound influence on a diverse array …

Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics

S Shou, A Maolan, D Zhang, X Jiang, F Liu, Y Li… - … Hematology & Oncology, 2025 - Springer
Telomeres and telomerase play crucial roles in the initiation and progression of cancer. As
biomarkers, they aid in distinguishing benign from malignant tissues. Despite the promising …

[PDF][PDF] Prognostic value of long non-coding RNA MALAT1 in hepatocellular carcinoma: A study based on multi-omics analysis and RT-PCR validation

X Liao, J Chen, DC Luo, B Luo, W Huang… - Pathology and …, 2022 - por-journal.com
Background: This study aimed to explore the relationship between MALAT1 and the
prognosis of patients with hepatocellular carcinoma (HCC). Methods: We constructed a …

The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia

A Pergaris, I Genaris, IE Stergiou, J Klijanienko… - Cancers, 2023 - mdpi.com
Simple Summary DAXX and HJURP are two proteins implicated in many physiologic
processes and are considered important players contributing to the pathogenesis of a …

Roles of lncRNA-MALAT1 in the Progression and Prognosis of Gliomas

YL Ji, K Kang, QL Lv, DP Wang - Mini Reviews in Medicinal …, 2024 - ingentaconnect.com
Long noncoding RNAs (lncRNAs) represent a large subgroup of RNA transcripts that lack
the function of coding proteins and may be essential universal genes involved in …

Beyond the genome: MALAT1's role in advancing urologic cancer care

M Imran, L Eltaib, MI Siddique, M Kamal… - … -Research and Practice, 2024 - Elsevier
Urologic cancers (UCs), which include bladder, kidney, and prostate tumors, account for
almost a quarter of all malignancies. Long non-coding RNAs (lncRNAs) are tissue-specific …

Unraveling the mechanisms of glioblastoma's resistance: investigating the influence of tumor suppressor p53 and non-coding RNAs

QA Alshammari, SO Alshammari, A Alshammari… - Naunyn-Schmiedeberg's …, 2024 - Springer
Glioblastoma (GB) is one of the most fatal CNS malignancies, and its high resistance to
therapy and poor outcomes have made it one of the primary challenges in oncology …

LINC00312 Inhibits Lung Cancer Progression through the miR-3175/SEMA6A Axis

X Zhang, Q Zhang, T Li, L Liu… - Critical Reviews™ in …, 2023 - dl.begellhouse.com
This study aims to clarify molecular mechanisms and tumor-associated functions of
LINC00312 in lung cancer. GEO database was used to acquire lung cancer-related …

[PDF][PDF] Diabetes Mellitus-Mediated MALAT1 Expression Induces Glioblastoma Aggressiveness

AA Kocaeli, SA Aksoy, M Erçelik… - Turkish …, 2023 - neurosurgery.dergisi.org
AIM: To describe the role of metastasis-associated lung adenocarcinoma transcript 1
(MALAT1) in glioblastoma (GB) progression in patients concurrently diagnosed with …

[引用][C] Glioblastoma tedavisinde kombin ilaç yüklü katmanlı nanolif yüzeylerin tasarımı ve kullanılabilirliğinin analizi

M Erçelik - 2024 - Bursa Uludağ Üniversitesi